DCGIDrugs Controller General of India
DCGIDepartment of Computer Graphics and Interaction (Czech Republic)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
The product information provided by pharmaceutical companies in India has been determined to be far from adequate and not conforming with the WHO recommendations and the requirements of DCGI. [3] Hence, this study was designed to assess the presentation and completeness of important clinical information in the available PIs in India.
" In this regard, the drug consultative committee has submitted its report to the DCGI, with some recommendations over the illegal sale of medicines online.
Seeking support from the industry, DCGI has requested all the pharma manufacturing units in the country take steps to ensure that persons employed by them are fully trained and certified.
The Controller General of India (DCGI) and Indian Council of Medical Research (ICMR) have established ADR monitoring centers in many hospitals in major cities of India.
The Indian Medical Association said it will ask the Drugs Controller General of India, or DCGI, to probe the quality of drugs sold by Ranbaxy Laboratories (BOM:500359) in India.
The scene becomes much murkier with disclosures of some pharmaceutical companies having been caught red-handed writing scientific recommendations of their own products and submitting them to the Drug Controller General of India (DCGI) after getting them endorsed by top specialists from the medical fraternity for a quicker marketing approval.
After completing the pre clinical trials of a new nano drug, Drug Controller General of India (DCGI) needs several years to understand about the drug, as the drug is new and takes time to grant the approval for conducting clinical trials (phase I) , thereafter it takes several years to market the drug.
Freedom Knee has received US FDA, Drugs Controller General of India (DCGI), and CE Mark approvals, making it the only system sold globally yet designed with features that specifically address Asian patients' needs.
The court, in an unusual event, directed the Drug Controller General of India (DCGI) to not allow any party to infringe any laws.
There should be review of data with Drugs Controller General of India (DCGI) and consultations should be held to review and where needed recommend amendments of schedule Y regulations for new products, devices ,drug delivery systems, plant extracts, vaccines, developed in India and other countries.
The trial was also approved by the Institutional Ethics Committee, the Drugs Controller General of India (DCGI), the Genetic Engineering Approval Committee (GEAC) of Ministry of Environment and Forests, the Health Ministry Screening Committee (HMSC), Government of India, the Scientific Advisory Sub-committee constituted by the ICMR, and the Central Ethics Committee of ICMR